The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Inhaler Advantages. Portability: Inhalers are small, portable, and easy to carry, making them convenient for on-the-go asthma management. Faster Onset: Inhalers deliver medication quickly to the lungs ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Research on the Digihaler highlights its potential to track COPD inhaler use, offering real-world data to improve treatment ...

Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD ...

The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown ...

Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute ...

A pilot study shows digital inhaler data can detect early signs of COPD exacerbations, offering promise for proactive disease ...

Approved PAH medications are predominately pulmonary vasodilators that modulate the endothelin, nitric oxide, and prostacyclin pathways. 34 These therapies primarily address the vasoconstrictive ...

Lupin has signed a licensing deal with China’s Sino Universal Pharmaceuticals to bring its Tiotropium inhaler to the Chinese market. The product, used for treating COPD, will be manufactured by ...